163 related articles for article (PubMed ID: 26503466)
1. A multi-stage process including transient polyploidization and EMT precedes the emergence of chemoresistent ovarian carcinoma cells with a dedifferentiated and pro-inflammatory secretory phenotype.
Rohnalter V; Roth K; Finkernagel F; Adhikary T; Obert J; Dorzweiler K; Bensberg M; Müller-Brüsselbach S; Müller R
Oncotarget; 2015 Nov; 6(37):40005-25. PubMed ID: 26503466
[TBL] [Abstract][Full Text] [Related]
2. Aberrant SERPINE1 DNA methylation is involved in carboplatin induced epithelial-mesenchymal transition in epithelial ovarian cancer.
Pan JX; Qu F; Wang FF; Xu J; Mu LS; Ye LY; Li JJ
Arch Gynecol Obstet; 2017 Dec; 296(6):1145-1152. PubMed ID: 28975405
[TBL] [Abstract][Full Text] [Related]
3. Danusertib Induces Apoptosis, Cell Cycle Arrest, and Autophagy but Inhibits Epithelial to Mesenchymal Transition Involving PI3K/Akt/mTOR Signaling Pathway in Human Ovarian Cancer Cells.
Zi D; Zhou ZW; Yang YJ; Huang L; Zhou ZL; He SM; He ZX; Zhou SF
Int J Mol Sci; 2015 Nov; 16(11):27228-51. PubMed ID: 26580601
[TBL] [Abstract][Full Text] [Related]
4. Notch3 induces epithelial-mesenchymal transition and attenuates carboplatin-induced apoptosis in ovarian cancer cells.
Gupta N; Xu Z; El-Sehemy A; Steed H; Fu Y
Gynecol Oncol; 2013 Jul; 130(1):200-6. PubMed ID: 23542683
[TBL] [Abstract][Full Text] [Related]
5. Tumor cells can escape DNA-damaging cisplatin through DNA endoreduplication and reversible polyploidy.
Puig PE; Guilly MN; Bouchot A; Droin N; Cathelin D; Bouyer F; Favier L; Ghiringhelli F; Kroemer G; Solary E; Martin F; Chauffert B
Cell Biol Int; 2008 Sep; 32(9):1031-43. PubMed ID: 18550395
[TBL] [Abstract][Full Text] [Related]
6. LY75 Suppression in Mesenchymal Epithelial Ovarian Cancer Cells Generates a Stable Hybrid EOC Cellular Phenotype, Associated with Enhanced Tumor Initiation, Spreading and Resistance to Treatment in Orthotopic Xenograft Mouse Model.
Mehdi S; Macdonald E; Galpin K; Landry DA; Rodriguez G; Vanderhyden B; Bachvarov D
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32679765
[TBL] [Abstract][Full Text] [Related]
7. SASP mediates chemoresistance and tumor-initiating-activity of mesothelioma cells.
Canino C; Mori F; Cambria A; Diamantini A; Germoni S; Alessandrini G; Borsellino G; Galati R; Battistini L; Blandino R; Facciolo F; Citro G; Strano S; Muti P; Blandino G; Cioce M
Oncogene; 2012 Jun; 31(26):3148-63. PubMed ID: 22020330
[TBL] [Abstract][Full Text] [Related]
8. Functional relevance of a six mesenchymal gene signature in epithelial-mesenchymal transition (EMT) reversal by the triple angiokinase inhibitor, nintedanib (BIBF1120).
Huang RY; Kuay KT; Tan TZ; Asad M; Tang HM; Ng AH; Ye J; Chung VY; Thiery JP
Oncotarget; 2015 Sep; 6(26):22098-113. PubMed ID: 26061747
[TBL] [Abstract][Full Text] [Related]
9. COM33 suppresses carboplatin-induced epithelial-mesenchymal transition via inhibition of Twist1 in ovarian cancer.
Zhou Z; Jin L; Shen J; Shi W; Xu Y; Ye L; Liu J; Pan J
Acta Biochim Biophys Sin (Shanghai); 2022 Dec; 55(1):34-42. PubMed ID: 36647720
[TBL] [Abstract][Full Text] [Related]
10. Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells.
Rosanò L; Cianfrocca R; Spinella F; Di Castro V; Nicotra MR; Lucidi A; Ferrandina G; Natali PG; Bagnato A
Clin Cancer Res; 2011 Apr; 17(8):2350-60. PubMed ID: 21220476
[TBL] [Abstract][Full Text] [Related]
11. Therapy-Induced Cellular Senescence Induces Epithelial-to-Mesenchymal Transition and Increases Invasiveness in Rectal Cancer.
Tato-Costa J; Casimiro S; Pacheco T; Pires R; Fernandes A; Alho I; Pereira P; Costa P; Castelo HB; Ferreira J; Costa L
Clin Colorectal Cancer; 2016 Jun; 15(2):170-178.e3. PubMed ID: 26603055
[TBL] [Abstract][Full Text] [Related]
12. Docetaxel-induced polyploidization may underlie chemoresistance and disease relapse.
Ogden A; Rida PC; Knudsen BS; Kucuk O; Aneja R
Cancer Lett; 2015 Oct; 367(2):89-92. PubMed ID: 26185000
[TBL] [Abstract][Full Text] [Related]
13. In vitro and ex vivo vanadium antitumor activity in (TGF-β)-induced EMT. Synergistic activity with carboplatin and correlation with tumor metastasis in cancer patients.
Petanidis S; Kioseoglou E; Domvri K; Zarogoulidis P; Carthy JM; Anestakis D; Moustakas A; Salifoglou A
Int J Biochem Cell Biol; 2016 May; 74():121-34. PubMed ID: 26916505
[TBL] [Abstract][Full Text] [Related]
14. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
Wang F; Li H; Yan XG; Zhou ZW; Yi ZG; He ZX; Pan ST; Yang YX; Wang ZZ; Zhang X; Yang T; Qiu JX; Zhou SF
Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225
[TBL] [Abstract][Full Text] [Related]
15. High-resolution genomic profiling of carboplatin resistance in early-stage epithelial ovarian carcinoma.
Osterberg L; Levan K; Partheen K; Staaf J; Sundfeldt K; Horvath G
Cytogenet Genome Res; 2009; 125(1):8-18. PubMed ID: 19617691
[TBL] [Abstract][Full Text] [Related]
16. HE4 promotes collateral resistance to cisplatin and paclitaxel in ovarian cancer cells.
Ribeiro JR; Schorl C; Yano N; Romano N; Kim KK; Singh RK; Moore RG
J Ovarian Res; 2016 May; 9(1):28. PubMed ID: 27184254
[TBL] [Abstract][Full Text] [Related]
17. Prolonged pemetrexed pretreatment augments persistence of cisplatin-induced DNA damage and eliminates resistant lung cancer stem-like cells associated with EMT.
Tièche CC; Peng RW; Dorn P; Froment L; Schmid RA; Marti TM
BMC Cancer; 2016 Feb; 16():125. PubMed ID: 26895954
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of metformin at low concentration on epithelial-mesenchymal transition of CD44(+)CD117(+) ovarian cancer stem cells.
Zhang R; Zhang P; Wang H; Hou D; Li W; Xiao G; Li C
Stem Cell Res Ther; 2015 Dec; 6():262. PubMed ID: 26718286
[TBL] [Abstract][Full Text] [Related]
19. A Bibenzyl from Dendrobium ellipsophyllum inhibits epithelial-to-mesenchymal transition and sensitizes lung cancer cells to anoikis.
Chaotham C; Pongrakhananon V; Sritularak B; Chanvorachote P
Anticancer Res; 2014 Apr; 34(4):1931-8. PubMed ID: 24692728
[TBL] [Abstract][Full Text] [Related]
20. [Combinative effects of FAP-1 antisense oligonucleotide and carboplatin on apoptosis of ovarian cancer cell SKOV3].
Wang B; Zheng WG; Xin XY; Qi RY; Yu YC; Cao YX
Ai Zheng; 2004 Aug; 23(8):885-9. PubMed ID: 15301708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
